Drugs of Abuse (DOA) Testing Market Size Forecasted To Achieve $11.67 Billion By 2029 With Steady Growth

The Drugs of Abuse (DOA) Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Drugs of Abuse (DOA) Testing Market Size During the Forecast Period?
The market size for drugs of abuse (DOA) testing has seen a robust growth in the previous years. The market, which was valued at $7.3 billion in 2024, is projected to reach $7.99 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The exceptional growth in the historic phase can be credited to governmental norms and office protocols, initial employment assessments, policing and legal actions, addiction recovery programs, and adherence in the transport industry.

Predictions for the drugs of abuse (DOA) testing market size are positive as robust growth is expected in the coming years. By 2029, the industry is estimated to be valued at $11.67 billion, with a compound annual growth rate (CAGR) of 9.9%. The projected growth during this forecast period could be a result of factors such as the escalation in sports and athletics testing, heightened awareness and education initiatives, increasing incidences of drug-related crimes, and the prevalence of corporate wellness programs. Furthermore, advances in testing techniques will also contribute to the market growth. Upcoming trends in the forecast period include the adoption of portable and handheld testing equipment, the implementation of laboratory information management systems (LIMS), a concentration on synthetic drug testing, a rising demand for cannabis* testing, and the incorporation of artificial intelligence (AI) in interpreting results.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9381

What Are the High-Growth Segments in the Drugs of Abuse (DOA) Testing Market?
The drugs of abuse (DOA) testing market covered in this report is segmented -

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

Subsegments:
1) By Analyzers: Immunoassay Analyzers, Chromatography-Based Analyzers, Mass Spectrometry Systems
2) By Rapid Testing Devices: Urine Test Kits, Saliva Test Kits, Hair Test Kits
3) By Consumables: Test Strips, Reagents, Sample Collection Devices
4) By Laboratory Services: Toxicology Testing, Confirmation Testing, Screening Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

What Key Drivers Are Expected to Influence Future Drugs of Abuse (DOA) Testing Market Growth?
The growth of the drug of abuse (DOA) testing market is anticipated to be driven by the growing need for drug abuse treatments. Substance abuse, also known as drug abuse, involves using a substance in quantities that are harmful to the user or others. Drug testing plays a crucial role in the identification of substances that are not usually present in the body. The procedure initiates with a screening test, followed by another test to identify or confirm the presence of a substance or substances, hence, the growing demand for drug abuse treatment will spur the market's growth. For example, in December 2023, it was publicized by the Government of the United Kingdom (GOV. UK), a government platform based in UK, that between April 2022 and March 2023, 290,635 adults sought drug and alcohol services, indicating a minor increase from 289,215 in the last year. Additionally, admissions for treatment also surged to 137,749, compared to the 130,490 and 133,704 in the previous two years. Consequently, the increasing demand for drug abuse treatment is fostering the growth of the drug of abuse (DOA) testing market.

Which Companies Hold the Largest Share Across Different Drugs of Abuse (DOA) Testing Market Segments?
Major companies operating in the drugs of abuse (DOA) testing market include Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

What Are the Latest Developing Trends in the Drugs of Abuse (DOA) Testing Market?
Leading firms in the Drugs of Abuse (DOA) testing market are striving to develop creative products like a software-as-a-service (SaaS) platform to consolidate their market presence. SaaS is a software provision model where applications are hosted by an external provider and accessible to clients via the internet. Take for example, in December 2023, the US-based science and technology firm Merck KGaA rolled out the Addison drug discovery software. It accelerates drug development and enhances the success potential of new medications and treatments by blending computer-assisted drug design, machine learning, and generative AI. The software subsequently proposes optimal methods to synthesize these drugs, linking the design of virtual molecules to their practical production. By extracting hidden insights from vast datasets, the platform increases the likelihood of patients benefiting from innovative therapies.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

What Are the Emerging Geographies for The Drugs of Abuse (DOA) Testing Market Growth?
North America was the largest region in the drugs of abuse (DOA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drugs of Abuse (DOA) Testing Market?
2. What is the CAGR expected in the Drugs of Abuse (DOA) Testing Market?
3. What Are the Key Innovations Transforming the Drugs of Abuse (DOA) Testing Industry?
4. Which Region Is Leading the Drugs of Abuse (DOA) Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.